BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Hepatol. May 27, 2026; 18(5): 117157
Published online May 27, 2026. doi: 10.4254/wjh.v18.i5.117157
Table 1 Baseline comparison table in giant hepatic hemangioma group, mean ± SD/n (%)/median (interquartile rage)

Liver subcapsular (n = 55)
Liver parenchymal (n = 17)
t/Z/χ2
P value
Age (years)48.00 ± 9.1247.47 ± 7.54-0.2170.829
Sex0.8720.350
    Female39 (72.72)10 (58.82)
    Male16 (27.27)7 (41.18)
BMI24.26 ± 3.1025.56 ± 3.481.4690.146
Size (cm)10.83 (10.33-13.80)10.50 (10.11-10.90)-1.7110.087
Location of main lesion3.5350.060
    Left lobe18 (30.91)1 (5.88)
    Right lobe37 (69.09)16 (94.12)
Hepatitis B virus3 (5.45)0 (0)
Reasons for operation0.0620.804
    Symptomatic10 (18.2)2 (11.8)
    Enlargement45 (81.8)15 (88.2)
Number of lesions2.1030.349
    119 (34.5)8 (47.1)
    29 (16.4)4 (23.5)
    Multiple27 (49.1)5 (29.4)
Inflammatory
    WBC (109/L)5.34 ± 1.825.06 ± 1.30-0.5810.563
    Neutrophil (%)57.60 (49.43-62.25)55.40 (49.28-63.80)-1.0480.295
    Hb (g/L)127.65 ± 21.51135.29 ± 17.141.3370.186
Liver function
    TB (μmol/L)12.54 ± 4.5612.41 ± 5.72-0.1010.920
    ALT (U/L)15.30 (10.25-28.00)24.5 (11.75-42.75)-1.5330.125
    AST (U/L)15.50 (14.00-19.75)20.50 (16.25-26.50)-1.9200.055
    GGT (U/L)18.00 (11.25-33.75)37.00 (17.75-54.50)-1.3600.174
Coagulation
    PT (seconds)11.62 ± 0.7211.69 ± 1.300.2990.766
    D-D (μg/L)292.00 (145.75-828.25)242.50 (141.00-526.50)-0.9450.345
Renal function
    Cr (μmol/L)65.30 ± 13.4067.41 ± 10.760.5910.556
    BUN (mg/dL)4.86 ± 1.214.79 ± 1.12-0.2070.837
Table 2 Baseline comparison table in large hepatic hemangioma group, mean ± SD/n (%)/median (interquartile rage)

Liver subcapsular (n = 63)
Liver parenchymal (n = 17)
t/Z/χ2
P value
Age (years)46.92 ± 10.76246.29 ± 11.22-0.2110.833
Sex0.0001.000
    Male14 (22.2)4 (23.5)
    Female49 (77.8)13 (76.5)
BMI24.44 ± 3.0724.68 ± 4.58-0.7310.803
Size (cm)7.20 ± 1.246.94 ± 1.180.7820.436
Location of main lesion1.3960.237
    Left lobe14 (22.2)1 (5.88)
    Right lobe49 (77.8)16 (94.12)
Number of lesions0.7200.698
    125 (39.7)7 (41.2)
    210 (15.9)4 (23.5)
    Multiple28 (44.4)6 (35.3)
Hepatitis B virus1 (1.59)0 (0)
Reasons for operation0.990
    Symptomatic5 (7.9)2 (11.8)
    Enlargement58 (92.1)15 (88.2)
Inflammatory
    WBC (109/L)5.26 ± 1.605.75 ± 1.61-1.1260.297
    Neutrophil (%)128.22 ± 15.58134.12 ± 12.65-1.4360.155
    Hb (g/L)51.40 (47.18-59.85)50.95 (46.08-61.18)-0.1120.911
Liver function
    TB (μmol/L)14.08 ± 13.4113.21 ± 6.100.2580.797
    ALT (U/L)12.00 (10.00-15.75)13.30 (11.00-16.75)-0.8070.420
    AST (U/L)15.00 (13.00-16.75)15.00 (12.88-19.00)-0.6050.545
    GGT (U/L)15.00 (13.00-19.50)25.50 (14.00-31.50)-1.4340.152
Coagulation
    PT (seconds)11.54 ± 0.5911.88 ± 1.16-1.6560.102
    D-D (μg/L)155.50 (133.25-214.50)183.00 (88.75-545.00)-0.9570.338
Renal function
    Cr (μmol/L)65.30 ± 11.2262.35 ± 14.420.9020.370
    BUN (mg/dL)4.81 ± 1.424.86 ± 1.49-0.1300.897
Table 3 Compare the postoperative recovery conditions of the liver subcapsular group and the liver parenchymal group in the large hepatic hemangioma group, mean ± SD/median (interquartile rage)

Liver subcapsular (n = 63)
Liver parenchymal (n = 17)
t/Z/χ2
P value
Inflammatory
    WBC (109/L)9.61 ± 2.839.14 ± 2.840.6070.545
    Neutrophil (%)83.13 ± 6.6780.85 ± 8.961.1620.249
Liver function
    TB (μmol/L)31.17 ± 14.0631.41 ± 10.21-0.0660.948
    ALT (U/L)281.70 (180.95-452.83)328.95 (191.15-596.55)-0.7470.455
    AST (U/L)413.30 (251.15-617.20)318.50 (221.43-705.93)-0.0060.955
    GGT (U/L)24.50 (17.25-39.75)43.50 (22.75-68.50)-1.8080.071
Renal function
    Cr (μmol/L)53.95 (47.65-64.58)58.50 (50.43-65.65)-0.9680.333
    BUN (mg/dL)3.30 (2.60-3.98)3.65 (2.82-4.25)-0.3410.733
Coagulation
    PT (seconds)12.18 ± 0.6412.70 ± 0.56-3.0260.003
    D-D (μg/L)2026 (1158-2534)2403 (2001-2645)-1.6070.108
Perioperative
    Ablation time (minutes)32.82 ± 9.5032.36 ± 9.200.1670.868
    Clinical stay (day)3.00 (3.00-3.00)3.00 (3.00-4.00)-0.7210.471
    Exhaust time (day)1.00 (1.00-2.00)1.50 (1.00-2.00)-0.4310.667
    Surgical blood loss (mL)10.00 (9.00-20.00)5.00 (5.00-10.00)-2.0530.040
    Spent61352 (47405-65220)56366 (47355-60906)-0.4890.625
Table 4 Compare the postoperative recovery conditions of the liver subcapsular group and the liver parenchymal group in the giant hepatic hemangioma group, mean ± SD/median (interquartile rage)

Liver subcapsular (n = 55)
Liver parenchymal (n = 17)
t/Z/χ2
P value
Inflammatory
    WBC (109/L)9.98 ± 3.589.58 ± 3.030.4080.685
    Neutrophil (%)86.40 (81.50-89.95)85.00 (80.25-90.85)-0.0970.923
Liver function2.00 (2.00-2.00)2.00 (1.50-2.50)-0.8850.376
    TB (μmol/L)41.60 (25.05-54.05)38.70 (24.70-52.25)-0.2250.822
    ALT (U/L)237.60 (157.30-473.90)338.60 (261.75-418.75)-1.4920.136
    AST (U/L)498.80 (284.75-685.65)482.20 (381.70-640.35)-0.5770.564
    GGT (U/L)40.00 (24.00-46.50)47.00 (23.50-60.50)-0.7360.462
Renal function
    Cr (μmol/L)56.20 (47.60-65.82)58.1 (48.90-68.25)-0.2450.806
    BUN (mg/dL)4.40 (3.60-5.40)4.00 (3.30-4.95)-0.7630.445
Coagulation
    PT (seconds)12.72 (12.40-12.72)12.58 (12.00-13.10)-1.1520.249
    D-D (μg/L)2822 (1597-2822)1936 (1442-3131)-1.5060.132
Perioperative
    Ablation time (minutes)50.09 ± 14.4843.71 ± 10.891.6710.099
    Clinical stay (day)3.00 (3.00-4.00)3.00 (2.00-4.00)-1.0100.312
    Spent60455 (57106-64849)60716 (56262-62966)-0.1660.868
    Exhaust time (day)2 (2-3)1.5 (1.25-2.5)-0.8850.376
    Surgical blood loss (mL)20.00 (10.00-50.00)20.00 (10.00-35.00)-0.0970.923
Table 5 Compare the postoperative recovery conditions of the giant hepatic hemangioma and large hepatic hemangioma groups in the liver parenchymal group, mean ± SD/median (interquartile rage)

GHH (n = 17)
LHH (n = 17)
t/Z/χ2
P value
Inflammatory
    WBC (109/L)9.58 ± 3.039.14 ± 2.840.4410.662
    Neutrophil (%)85.00 (80.25-89.93)82.40 (73.75-89.70)-1.0510.293
Liver function
    TB (μmol/L)42.61 ± 23.3731.41 ± 10.211.8090.080
    ALT (U/L)375.63 ± 157.13378.32 ± 234.54-0.0390.969
    AST (U/L)559.81 ± 257.56479.50 ± 337.710.7800.441
    GGT (U/L)41.00 (19.50-79.75)42.50 (25.75-63.00)-0.6890.491
Renal function
    Cr (μmol/L)59.50 (52.60-65.50)58.1 (48.90-68.25)-0.3620.718
    BUN (mg/dL)5.60 (3.33-12.38)3.35 (2.95-4.07)-1.7580.079
Coagulation
    D-D (μg/L)1935.05 ± 1315.622403.25 ± 2441.19-1.0030.596
    PT (seconds)12.58 ± 1.1212.70 ± 0.85-0.4490.793
Perioperative
    Spent60716.60 (56261.64-62966.02)56527.12 (47523.46-60886.15)-1.7050.088
    Ablation time (minutes)43.71 ± 10.8932.29 ± 8.293.4380.002
    Exhaust time (day)2.00 (1.25-2.75)1.50 (1.00-2.00)-2.9250.003
    Surgical blood loss (mL)30.00 (6.25-50.00)15.00 (6.25-42.50)-2.5530.011
    Clinical stay (day)3.00 (2.00-4.00)3.00 (3.00-4.00)-0.8290.407
Table 6 Compare the postoperative recovery conditions of the giant hepatic hemangioma and large hepatic hemangioma groups within the liver subcapsular group, mean ± SD/median (interquartile rage)

GHH (n = 55)
LHH (n = 63)
t/Z/χ2
P value
Inflammatory
    WBC (109/L)85.58 ± 6.1383.11 ± 6.672.0710.041
    Neutrophil (%)9.98 ± 3.589.61 ± 2.830.6180.538
Liver function
    TB (μmol/L)39.35 (26.30-55.60)32.10 (22.23-37.23)-3.0670.002
    ALT (U/L)201.40 (131.40-372.95)280.55 (181.88-460.90)-0.3100.756
    AST (U/L)462.40 (240.05-626.98)396.35 (271.80-647.13)-1.3870.165
    GGT (U/L)38.00 (22.25-61.75)22.00 (15.00-27.25)-2.9280.003
Renal function
    Cr (μmol/L)61.15 (44.65-88.10)55.75 (47.80-64.58)-0.7580.448
    BUN (mg/dL)4.89 (3.85-6.37)3.60 (2.80-3.98)-4.466< 0.001
Coagulation
    D-D (μg/L)1909.50 (996.25-5124.50)1339.50 (719.50-3002.00)-2.4850.013
    PT (seconds)12.72 (12.40-12.72)12.18 (11.90-15.50)-3.985< 0.001
Perioperative
    Spent60846.12 (53898.31-64930.00)55564.91 (36598.66-62983.01)-1.5130.130
    Exhaust time (day)2.00 (2.00-2.00)1.00 (1.00-2.00)-4.606< 0.001
    Ablation time (minutes)50.00 (40.00-60.00)30.50 (28.00-37.75)-6.346< 0.001
    Clinical stay (day)3.00 (3.00-4.00)3.00 (2.00-3.00)-1.3610.173
    Surgical blood loss (mL)20.00 (10.00-45.00)10.00 (5.25-20.00)-2.1790.029
Table 7 Comparison of postoperative complications between giant hepatic hemangioma and large hepatic hemangioma groups, n (%)

GHH (n = 72)
LHH (n = 80)
χ2
P value
Anemia19 (26.39)12 (15)3.0270.082
Fever40 (55.56)8 (10)36.398< 0.001
Hemoglobinuria8 (11.11)9 (11.25)0.0010.987
Acute kidney injury1 (1.39)1 (1.25)1.000
Hypoproteinemia3 (4.17)0 (0)4.5500.033
Table 8 Comparison of postoperative complications between liver subcapsular and liver parenchymal groups, n (%)

Liver subcapsular (n = 118)
Liver parenchymal (n = 34)
χ2
P value
Anemia23 (19.49)8 (23.53)0.2650.607
Fever31 (26.27)17 (50)6.8780.009
Hemoglobinuria15 (12.71)1 (2.94)1.7390.187
Acute kidney injury1 (0.8)1 (2.94)0.398
Hypoproteinemia2 (1.69)1 (2.94)0.535


Write to the Help Desk